Russell Investments Group Ltd. Has $324,000 Position in GRAIL, Inc. $GRAL

Russell Investments Group Ltd. cut its position in GRAIL, Inc. (NASDAQ:GRAL) by 83.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 12,673 shares of the company’s stock after selling 65,244 shares during the quarter. Russell Investments Group Ltd.’s holdings in GRAIL were worth $324,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in GRAL. State of Tennessee Department of Treasury acquired a new position in GRAIL in the 4th quarter valued at approximately $28,000. Caldwell Sutter Capital Inc. acquired a new position in GRAIL during the 1st quarter worth about $28,000. KBC Group NV grew its position in shares of GRAIL by 187.7% in the 1st quarter. KBC Group NV now owns 1,430 shares of the company’s stock valued at $37,000 after buying an additional 933 shares during the last quarter. S.A. Mason LLC increased its stake in shares of GRAIL by 50.1% in the first quarter. S.A. Mason LLC now owns 1,499 shares of the company’s stock valued at $38,000 after buying an additional 500 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in shares of GRAIL in the fourth quarter worth approximately $41,000.

Wall Street Analyst Weigh In

Separately, Canaccord Genuity Group increased their target price on shares of GRAIL from $32.00 to $43.00 and gave the company a “buy” rating in a research report on Wednesday, May 14th. One investment analyst has rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $31.50.

Insider Buying and Selling at GRAIL

In related news, President Joshua J. Ofman sold 4,202 shares of GRAIL stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $32.02, for a total value of $134,548.04. Following the completion of the sale, the president owned 487,874 shares of the company’s stock, valued at approximately $15,621,725.48. This trade represents a 0.85% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Aaron Freidin sold 8,000 shares of the business’s stock in a transaction on Tuesday, July 15th. The shares were sold at an average price of $38.93, for a total transaction of $311,440.00. Following the sale, the chief financial officer owned 286,020 shares of the company’s stock, valued at $11,134,758.60. This trade represents a 2.72% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 361,694 shares of company stock valued at $17,780,266.

GRAIL Trading Down 3.9%

GRAL stock opened at $32.79 on Tuesday. The firm has a market cap of $1.18 billion, a PE ratio of -2.50 and a beta of 3.20. The stock has a 50-day moving average price of $37.81 and a 200-day moving average price of $36.08. GRAIL, Inc. has a 1-year low of $12.33 and a 1-year high of $63.99.

GRAIL (NASDAQ:GRAL) last released its quarterly earnings data on Tuesday, August 12th. The company reported ($3.18) earnings per share for the quarter, missing the consensus estimate of ($3.14) by ($0.04). GRAIL had a negative net margin of 329.86% and a negative return on equity of 16.64%. The company had revenue of $35.54 million during the quarter, compared to the consensus estimate of $37.57 million. On average, analysts forecast that GRAIL, Inc. will post -15.15 earnings per share for the current year.

About GRAIL

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.